APA

Liva S. G., Tseng Y., Dauki A. M., Sovic M. G., Vu T., Henderson S. E., Kuo Y., Benedict J. A., Zhang X., Remaily B. C., Kulp S. K., Campbell M., Bekaii-Saab T., Phelps M. A., Chen C. & Coss C. C. (20210727). Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. : EMBO molecular medicine.

Chicago

Liva Sophia G, Tseng Yu-Chou, Dauki Anees M, Sovic Michael G, Vu Trang, Henderson Sally E, Kuo Yi-Chiu, Benedict Jason A, Zhang Xiaoli, Remaily Bryan C, Kulp Samuel K, Campbell Moray, Bekaii-Saab Tanios, Phelps Mitchell A, Chen Ching-Shih and Coss Christopher C. 20210727. Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. : EMBO molecular medicine.

Harvard

Liva S. G., Tseng Y., Dauki A. M., Sovic M. G., Vu T., Henderson S. E., Kuo Y., Benedict J. A., Zhang X., Remaily B. C., Kulp S. K., Campbell M., Bekaii-Saab T., Phelps M. A., Chen C. and Coss C. C. (20210727). Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. : EMBO molecular medicine.

MLA

Liva Sophia G, Tseng Yu-Chou, Dauki Anees M, Sovic Michael G, Vu Trang, Henderson Sally E, Kuo Yi-Chiu, Benedict Jason A, Zhang Xiaoli, Remaily Bryan C, Kulp Samuel K, Campbell Moray, Bekaii-Saab Tanios, Phelps Mitchell A, Chen Ching-Shih and Coss Christopher C. Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. : EMBO molecular medicine. 20210727.